Results 251 to 260 of about 61,475 (266)

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience

International Journal of Radiation Oncology Biology Physics, 2004
Anthony Tak Cheung Chan, Benny Chung-Ying Zee, W H Kwan   +2 more
exaly  

Clinical Outcomes and Patterns of Failure After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma

International Journal of Radiation Oncology Biology Physics, 2011
Wai Tong Ng, Anne Wm Lee, OSCAR S H Chan
exaly  

Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone

International Journal of Radiation Oncology Biology Physics, 2005
Eng-Yen Huang
exaly  

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study

Annals of Oncology, 2002
W H Lau, H H Y Yiu, W Foo
exaly  

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

Annals of Oncology, 2002
S S Leong, E H Tan
exaly  

Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000–2011

Seminars in Cancer Biology, 2012
Cheng-Ping Wang, Allan Hildesheim
exaly  

Reirradiation of nasopharyngeal carcinoma withintensity-modulated radiotherapy

Radiotherapy and Oncology, 2005
Jonathan S T Sham, Gordon K H Au, Daniel T T Chua   +2 more
exaly  

Treatment Outcomes After Radiotherapy Alone for Patients With Early-Stage Nasopharyngeal Carcinoma

International Journal of Radiation Oncology Biology Physics, 2009
Fei Han, Weiwei Xiao, Chong Zhao
exaly  

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

Ca-A Cancer Journal for Clinicians
Yin Zhao, Wenfei Li, Na Liu
exaly  

<p>Management of recurrent nasopharyngeal carcinoma: current perspectives</p>

OncoTargets and Therapy, 2019
Francesco Perri, Raffaele Solla, Francesco Longo   +2 more
exaly